Allergy, Asthma and Immunology Clinic
3113 N. Sepulveda Blvd|
Manhattan Beach, CA 90266
(310) 802-8016 - Phone
(310) 802-8031 - Fax
Dr. Songs Allergy Bulletin
The seasonal flu vaccine for 2011 is available at our office.
The vaccine is recommended for children aged 6 months up to their 19th birhday, pregnantg women, people over 50 years of age and older, and people with chronic disease including asthma.You may get this vaccination at our office or any place offering the vaccine including your primary doctor's office.
The H1N1 (swine flu) vaccine is not available yet. The recommendation for vaccination is different from the seasonal flu one.
The best information is available at CDC web site. The following is the reprint of CDC recommendation.
CDC's Advisory Committee on Immunization Practices (ACIP) has recommended that certain groups of the population receive the novel H1N1 vaccine when it first becomes available. These key populations include pregnant women, people who live with or care for children younger than 6 months of age, healthcare and emergency medical services personnel, persons between the ages of 6 months and 24 years old, and people ages of 25 through 64 years of age who are at higher risk for novel H1N1 because of chronic health disorders or compromised immune systems.
We do not expect that there will be a shortage of novel H1N1 vaccine, but availability and demand can be unpredictable. There is some possibility that initially the vaccine will be available in limited quantities. In this setting, the committee recommended that the following groups receive the vaccine before others: pregnant women, people who live with or care for children younger than 6 months of age, health care and emergency medical services personnel with direct patient contact, children 6 months through 4 years of age, and children 5 through 18 years of age who have chronic medical conditions.
The committee recognized the need to assess supply and demand issues at the local level. The committee further recommended that once the demand for vaccine for these prioritized groups has been met at the local level, programs and providers should begin vaccinating everyone from ages 25 through 64 years. Current studies indicate the risk for infection among persons age 65 or older is less than the risk for younger age groups. Therefore, as vaccine supply and demand for vaccine among younger age groups is being met, programs and providers should offer vaccination to people over the age of 65.
Singulair News Letter
Allergy, Asthma and Immunology